6. Experience Of Surgical Treatments Of Xdr-Tb Patients With New Andrepurposed Preparations Chemotherapy

Authors

  • K.D. Yerimbetov National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • B.U. Bektursinov National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • Zh.A. Ibrayev National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • M.R. Rashitov National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • E.Zh. Algozhin National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • E.A. Aubakirov National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan
  • B.T. Toxanbayeva National scientific center of phthisiopulmonology, Ministry of health of the Republic of Kazakhstan, NGO «Partners in Health», Almaty, Kazakhstan

Downloads

Abstract

Performed analysis of experience sing surgical methods of treatment of 22 patients with M/XDR-TB with chemotherapy by new and repurposed preparations. Clinical surgical efficiency was achieved in 20 (91.0%) patients with mortality in 2 (9.0%) patients. Of the 14 patients who completed the full course of chemotherapy, the outcomes of treatment were “Cured” in 7 (31.8%), “treatment completed” in -5 (22.7%) patients, and “died” in 2 (14.3%). Other 8 (36.4%) patients continue treatment. The outcome “Treatment success” was obtained in 12 (85.7%) patients.

Keywords

thoracic surgery, combined Echinococcus

References

  1. World Health Organization. Global tuberculosis report
  2. World Health Organization. Global tuberculosis report
  3. Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928–952
  4. D’Ambrosio L, Dara M, Tadolini M, et al. Tuberculo-sis elimination: theory and practice in Europe. Eur Respir J 2014; 43: 1410–1420;
  5. Migliori GB, Sotgiu G,Gandhi NR, et al. Drug re-sistance beyond extensively drug-resistant tuber-culosis: individual patient data meta-analysis. Eur Respir J 2013; 42: 169–179
  6. Grzybowski S, Enarson DA. The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc Lung Dis 1978; 53: 70–75
  7. Michael Marrone, Giovanni Battista Migliori, Yerim-betov K.D, Giovanni Sotgiu., et.al. The role of sur-gery in the treatment of pulmonary TB and multidrug-and extensively drug-resistant TB /World Health organization(WHO), Regional offis for Europe, 2014
  8. Практические рекомендации по использованию краткосрочных, стандартных и индивидуальных режимов лечения РУ и М/ШЛУ ТБ с примене-ниемновых и перепрофилированных противо-туберкулезных препаратов /ННЦФ МЗ РК, 2018

Published

2019-12-01

Issue

No. 4 (2019)

Section

Статьи